Changing medication use in managed care: A critical review of the available evidence

American Journal of Managed Care

Volumn 9, Issue 11, 2003, Pages 715-731

  Pearson, Sallie Anne ^a   Ross Degnan, Dennis ^a   Payson, Ann ^a   Soumerai, Stephen B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ATENOLOL; BENAZEPRIL; BRONCHODILATING AGENT; CIMETIDINE; DRUG; ESTROGEN; FAMOTIDINE; FEXOFENADINE; GLUCOSE; HEMOGLOBIN A1C; HERBACEOUS AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; LIPID; LORATADINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METOPROLOL; NIFEDIPINE; RANITIDINE; SHORT ACTING DRUG; SIMVASTATIN; STEROID; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ANXIETY; ANXIETY DISORDER; ARTHROPATHY; ASTHMA; BEHAVIOR THERAPY; BRONCHITIS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; COUNSELING; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG USE; DRUG UTILIZATION; DYSTHYMIA; EVIDENCE BASED MEDICINE; FALLING; FEEDBACK SYSTEM; FINANCIAL MANAGEMENT; GENERALIZED ANXIETY DISORDER; GERIATRIC DISORDER; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HEART DISEASE; HELICOBACTER INFECTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIFESTYLE; LONG TERM CARE; LUNG DISEASE; MANAGED CARE ORGANIZATION; MEDICAL LITERATURE; METHODOLOGY; ORAL REHYDRATION THERAPY; OTITIS MEDIA; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PHARYNGITIS; PHYSICIAN INCOME; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; RISK; SAMPLING; SHORT COURSE THERAPY; STREPTOCOCCUS GROUP A; UNITED STATES; URINE INCONTINENCE; WOUND CARE;

DISEASE MANAGEMENT; DRUG UTILIZATION REVIEW; EDUCATION, MEDICAL, CONTINUING; EVIDENCE-BASED MEDICINE; HUMANS; MANAGED CARE PROGRAMS; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 0347844979     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Aventis Pharmaceuticals Inc. HMO-PPO/Medicare-Medicaid Digest: Managed Care Digest Series. Bridgewater, NJ: Aventis Pharmaceuticals; 2002.
2. Wassenaar JD, Thran SL, eds. Physician Socioeconomic Statistics: 2000-2002 Edition. Chicago, Ill: American Medical Association; 2001.
3. 2001 Managed Care Formulary Drug Audit. Newtown, Pa: Scott-Levin; 2002.
4. Litton LM, Sisk FA, Akins ME. Managing drug costs: The perception of managed care pharmacy directors. Am J Manag Care. 2000;6:805-814.
5. Gold MR, Hurley R, Lake T, Ensor T, Berenson RA. A national survey of the arrangements managed-care plans make with physicians. N Engl J Med. 1995;333:1678-1683.
6. Mays GP, Hurley RE, Grossman JM. Consumers face higher costs as health plans seek to control drug spending. Center for Studying Health System Change. 2001;45:1-4.
7. Bodenheimer T. Disease management - Promises and pitfalls. N Engl J Med. 1999;340:1202-1205.
8. Welch WP, Bergsten C, Cutler C, Bocchino C, Smith RI. Disease management practices of health plans. Am J Manag Care. 2002;8:353-361.
9. Cook TD, Campbell DT. Quasi-Experimentation: Design & Analysis Issues for Field Settings. Boston, Mass: Houghton Mifflin Company; 1979.
10. Powell KM, Edgren B. Failure of educational videotapes to improve medication compliance in a health maintenance organization. Am J Health Syst Pharm. 1995;52:2196-2199.
11. Gonzales R, Steiner JF, Lum A, Barrett PH Jr. Decreasing antibiotic use in ambulatory practice: Impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA. 1999;281:1512-1519.
12. Duggan C, Lasche J, McCarty M, et al. Oral rehydration solution for acute diarrhea prevents subsequent unscheduled follow-up visits. Milbank Q. 1999;104:e29.
13. Sclar DA, Chin A, Skaer TL, et al. Effect of health education in promoting prescription refill compliance among patients with hypertension. Clin Ther. 1991;13:489-495.
14. Soumerai SB, McLaughlin TS, Avorn J. Improving drug prescribing in primary care: A critical analysis of the experimental literature. Milbank Q. 1989;67:268-317.
15. Finkelstein JA, Davis RL, Dowell SF, et al. Reducing antibiotic use in children: A randomized trial in 12 practices. Milbank Q. 2001;108:1-7.
16. Legorreta AP, Leung KM, Berkbigler D, Evans, Liu R. Outcomes of a population-based asthma management program: Quality of life, absenteeism, and utilization. Ann Allergy Asthma Immunol. 2000;85:28-34.
17. Brown JB, Shye D, McFarland BH, et al. Controlled trials of CQI and academic detailing to implement a clinical practice guideline for depression. Jt Comm J Qual Improv. 2000;26:39-54.
18. Gregory C, Cifaldi M, Tanner LA. Targeted intervention programs: Creating a customized practice model to improve the treatment of allergic rhinitis in a managed care population. Am J Manag Care. 1999;5:485-496.
19. Santos R, Cifaldi M, Gregory C, Seitz P. Economic outcomes of a targeted intervention program: The costs of treating allergic rhinitis patients. Am J Manag Care. 1999;5:S225-S234.
20. Soumerai SB, Avorn J. Principles of educational outreach ("academic detailing") to improve clinical decision making. JAMA. 1990;263:549-556.
21. Lee M, Kemp JA, Canning A, et al. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med. 1999;159:2312-2316.
22. Eisenberg JM. Doctors' Decisions and the Cost of Medical Care. Ann Arbor, Mich: Health Administration Press Perspectives; 1986.
23. Johnson RE, Campbell WH, Azevedo DJ, Christensen DB. Studying the impact of patient drug profiles in an HMO. Med Care. 1976;14:799-807
24. Schectman JM, Kanwal NK, Schroth WS, Elinsky EG. The effect of an education and feedback intervention on group-model and network-model health maintenance organization physician prescribing behavior. Med Care. 1995;33:139-144.
25. Benedetto SR, Sloan AS, Duncan BS. Impact of interventions designed to increase market share and prescribing of fexofenadine at HMOs. Am J Health Syst Pharm. 2000;57:1778-1785.
26. Winickoff RN, Wilner S, Neisuler R, Barnett GO. Limitations of provider interventions in hypertension quality assurance. Am J Public Health. 1985;75:43-46.
27. Simon GE, Von Korff M, Rutter C, Wagner E. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ. 2000;320:550-554.
28. Barnett GO, Winickoff R, Dorsey JL, Morgan MM, Lurie RS. Quality assurance through automated monitoring and concurrent feedback using a computer-based medical information system. Med Care. 1978;16:962-970.
29. Barnett GO, Winickoff RN, Morgan MM, Zielstorff RD. A computer-based monitoring system for follow-up of elevated blood pressure. Med Care. 1983;21:400-409.
30. Brufsky JW, Ross-Degnan D, Calabrese D, Gao X, Soumerai SB. Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization. Med Care. 1998;36:321-332.
31. Kaplan RC, Psaty BM, Kriesel D, et al. Replacing short-acting nifedipine with alternative medications at a large health maintenance organization. Am J Hypertens. 1998;11:471-477.
32. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989;262:914-919.
33. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA. 1995;273:1026-1031.
34. Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: A randomized trial. Arch Gen Psychiatry. 1999;56:1109-1115.
35. Lin EH, Von Korff M, Russo J, et al. Can depression treatment in primary care reduce disability? A stepped care approach. Arch Fam Med. 2000;9:1052-1058.
36. Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53:924-932.
37. Katon W, Rutter C, Ludman EJ, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry. 2001;58:241-247.
38. Simon GE, Katon W, Rutter C, et al. Impact of improved depression treatment in primary care on daily functioning and disability. Psychol Med. 1998;28:693-701.
39. Lin EH, Simon GE, Katon WJ, et al. Can enhanced acute-phase treatment of depression improve long-term outcomes? A report of randomized trials in primary care. Am J Psychiatry. 1999;156:643-645.
40. Von Korff M, Katon W, Bush T, et al. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med. March/April 1998;60:143-149.
41. Katzelnick DJ, Simon GE, Pearson SD, et al. Randomized trial of a depression management program in high utilizers of medical care. Arch Fam Med. 2000;9:345-351.
42. Katon W, Von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care. 1992;30:67-76.
43. Hunkeler EM, Meresman JF, Hargreaves WA, et al. Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Arch Fam Med. 2000;9:700-708.
44. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: A randomized controlled trial. JAMA. 2000;283:212-220.
45. Sherbourne CD, Wells KB, Duan NH, et al. Long-term effectiveness of disseminating quality improvement for depression in primary care. Arch Gen Psychiatry. 2001;58:696-703.
46. Schoenbaum M, Unutzer J, Sherbourne C, et al. Cost-effectiveness of practice-initiated quality improvement for depression: Results of a randomized controlled trial. JAMA. 2001;286:1325-1330.
47. Meredith LS, Jackson-Triche M, Duan NH, et al. Quality improvement for depression enhances long-term treatment knowledge for primary care clinicians. J Gen Intern Med. 2000;15:868-877.
48. Franco K, Tamburino M, Campbell N, et al. The added costs of depression to medical care. PharmacoEconomics. 1995;7(4):284-291.
49. Price D, Beck A, Nimmer C, Bensen S. The treatment of anxiety disorders in a primary care HMO setting. Psychiatr Q. 2000;71:31-45.
50. The Diabetes Control and Complications Research Group. The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
51. O'Connor PJ, Rush WA, Peterson J, et al. Continuous quality improvement can improve glycemic control for HMO patients with diabetes. Arch Fam Med. 1996;5:502-506.
52. Wagner EH, Grothaus LC, Sandhu N, et al. Chronic care clinics for diabetes in primary care: A system-wide randomized trial. Diabetes Care. 2001;24:695-700.
53. Sadur CN, Moline N, Costa M, et al. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care. 1999;22:2011-2017.
54. Kelly C, Rodgers PT. Implementation and evaluation of a pharmacist-managed diabetes service. J Manag Care Pharm. 2000;6:488-493.
55. Aubert RE, Herman WH, Waters J, et al. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial. Ann Intern Med. 1998;129:605-612.
56. DeBusk RF, Miller NH, Superko HR, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med. 1994;120:721-729.
57. Beck A, Scott J, Williams P, et al. A randomized trial of group outpatient visits for chronically ill older HMO members: The Cooperative Health Care Clinic. J Am Geriatr Soc. 1997;45:543-549.
58. Coleman EA, Grothaus LC, Sandhu N, Wagner EH. Chronic care clinics: A randomized controlled trial of a new model of primary care for frail older adults. J Am Geriatr Soc. 1999;47:775-783.
59. Johnston B, Wheeler L, Deuser J, Sousa KH. Outcomes of the Kaiser Permanente Tele-Home Health Research Project. Arch Fam Med. 2000;9:40-45.
60. Freemantle N, Harvey EL, Wolf F, et al. Printed educational materials to improve the behavior of health care professionals and patient outcome [update software]. Cochrane Database Syst Rev. 2002;3.
61. Anderson GM, Lexchin J. Strategies for improving prescribing practice. Can Med Assoc J. 1996;154:1013-1017.
62. Implementing clinical guidelines. Can guidelines be used to improve clinical practice? Effective Health Care. 1994:1(8).
63. Grimshaw JM, Shirran L, Thomas R, et al. Changing provider behavior: An overview of systematic reviews of interventions. Med Care. 2001;39:II2-45.
64. Shortell SM, Bennett CL, Byck GR. Assessing the impact of continuous quality improvement on clinical practice: What will it take to accelerate progress. Milbank Q. 1998;76:1-37.
65. Mugford M, Banfield P, O'Hanlon M. Effects of feedback of information on clinical practice. BMJ. 1991;303:398-402.
66. Thomson MA, Oxman AD, Davis DA, et al. Audit and feedback to improve health professional practice and health care outcomes, part I [update software]. Cochrane Database Syst Rev. 1998;1.
67. Thomson MA, Oxman AD, Davis DA, et al. Audit and feedback to improve health professional practice and health care outcomes, part II [update software]. Cochrane Database Syst Rev. 1998;1.
68. Mujumdar SR, Soumerai SB, Lee M, Ross-Degnan D. Designing an intervention to improve the management of Helicobacter pylori infection. Jt Com Qual Improv. 2001;27:405-414.